We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
61 hedge funds and large institutions have $84.3M invested in State Street SPDR S&P Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
8.9% less ownership
Funds ownership: 52.78% → 43.87% (-8.9%)
16% less funds holding
Funds holding: 73 → 61 (-12)
22% less capital invested
Capital invested by funds: $108M → $84.3M (-$23.8M)
58% less call options, than puts
Call options by funds: $366K | Put options by funds: $878K
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Holders
61
Holders Change
-12
Holders Change %
-16.44%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
18
Reduced
17
Closed
17
Calls
$366K
Puts
$878K
Net Calls
-$512K
Net Calls Change
-$373K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.12M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.86M |
| 3 |
CI
CX Institutional
Auburn,
Indiana
|
+$819K |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$700K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$431K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.9M |
| 2 |
Morgan Stanley
New York
|
-$2.41M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$1.46M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.41M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.25M |
